ArticlePharmaceuticals (Basel, Switzerland)2022
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy.
Jessica Cusato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.